| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.036 | 0.2 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.061 | 0.2 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.2 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.057 | 0.2 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.06 | 0.2 |